The CRE RESPOND Forum was held to share our latest updates and developments in reducing antimicrobial resistance through optimised dosing. Over the past two and a half years, our team, together with PhD students, has actively collaborated with centres and hospitals worldwide to continue our activity around optimised antimicrobial use. This forum presented some of our most recent exciting data and we hope that it will provide a springboard from which to plan for future innovations in clinical practice in infectious disease.